4//SEC Filing
Rosenblum Mark J 4
Accession 0001615219-22-000004
CIK 0001615219other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:03 PM ET
Size
5.4 KB
Accession
0001615219-22-000004
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Stock Option (right to buy)
2022-01-20+200,000→ 200,000 totalExercise: $0.48Exp: 2032-01-19→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]25% of the options are fully vested on January 19, 2023, and 1/36 of the remaining options vest on each monthly anniversary thereafter.
Documents
Issuer
Salarius Pharmaceuticals, Inc.
CIK 0001615219
Entity typeother
Related Parties
1- filerCIK 0001329154
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:03 PM ET
- Size
- 5.4 KB